GROWTH BUYOUT & VENTURE CAPITAL

Engaged Partnership - A long-term view.
The essentials for transformative growth in life sciences.

 


Latest Investment

Alladapt Immunotherapeutics is a privately held biopharmaceutical company developing prescription therapeutics targeting food allergy. The Company’s lead program, ADP101, is being

News

2020-02-28

Innocoll Holdings Limited Resubmits New Drug Application to FDA for XARACOLL® for the Management of Postsurgical Pain after Open Inguinal Hernia Surgery